Page last updated: 2024-08-05 11:28:02

pyrrolopyrazine

null

ChEBI ID: 48337

Members (7)

MemberDefinitionRole
brevianamide fA pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline).brevianamide F
cyclo(leucyl-prolyl)A homodetic cyclic peptide composed from leucyl and prolyl residues.cyclo(L-Leu-L-Pro)
histidyl-proline diketopiperazineA homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH).cyclo(L-His-L-Pro)
maculosinA homodetic cyclic peptide that is a dipeptide composed of L-proline and L-tyrosine joined by peptide linkages.maculosin
tryprostatin aA cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at positions 2 and 6 on the indole ring by prenyl and methoxy groups respectively.tryprostatin A
tryprostatin bA cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at position 2 on the indole ring by a prenyl group.tryprostatin B
zopicloneA pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.zopiclone

Research

Studies (785)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990137 (17.45)18.7374
1990's172 (21.91)18.2507
2000's226 (28.79)29.6817
2010's206 (26.24)24.3611
2020's44 (5.61)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials204 (24.09%)5.53%
Reviews86 (10.15%)6.00%
Case Studies69 (8.15%)4.05%
Observational5 (0.59%)0.25%
Other483 (57.02%)84.16%